A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients By Guilherme GuainJune 30, 2022
Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study By Guilherme GuainJune 30, 2022
A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression By Guilherme GuainJune 30, 2022
Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial By Guilherme GuainJune 30, 2022
Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial By Guilherme GuainJune 30, 2022
Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials By Guilherme GuainJune 30, 2022
Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial By Guilherme GuainJune 30, 2022
Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial By Guilherme GuainJune 30, 2022
Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial By Guilherme GuainJune 30, 2022
Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial By Guilherme GuainJune 30, 2022
